Photo:
shformacion.es
Apr 19, 2026, 13:52
David Montani: SOX17 Variants and Their Broader Impact in Pulmonary Arterial Hypertension
David Montani, Professor of Pulmonology and Hospital Practitioner at Paris-Saclay University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Cardiology:
“Happy to share this editorial, written with Thomas Lacoste-Palasset, Julien Grynblat, Grégoire Ruffenach, and Florence Coulet: ‘SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype’.”
Title: SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype
Authors: Thomas Lacoste-Palasset, Julien Grynblat, Gregoire Ruffenach, Florence Coulet, David Montani
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 24, 2026, 21:09Ifeanyichukwu Ifechidere: The Monitoring Dilemma in DOAC Therapy – Concentration vs. Real-Time Effect
-
Jul 24, 2026, 20:14Idris Syed: Presenting Our Omics and VTE Research at ISTH 2026
-
Jul 24, 2026, 19:58Wolfgang Miesbach: Why Patient-Reported Outcomes (PROs) Are Essential for Hemophilia Gene Therapy
-
Jul 24, 2026, 19:43Emilie Langenhan: An Unforgettable Experience at ISTH 2026
-
Jul 24, 2026, 17:16Mona Ranade։ Can Artificial Intelligence Accelerate Stroke Treatment?
-
Jul 24, 2026, 17:06Eunice Obinna: Hemoglobin and Hematocrit – What Do They Really Tell Us?
-
Jul 24, 2026, 16:52Subodh Grewal: RBC and Platelet Histogram Interpretation
-
Jul 24, 2026, 16:47Samwel Mikaye: Advancing the Global Fight Against Postpartum Hemorrhage
-
Jul 24, 2026, 16:17Michele Spino Bolles: How Stroke Certification Standards Improve Patient Outcomes